Uffe Ravnskov

3.3k total citations
75 papers, 1.9k citations indexed

About

Uffe Ravnskov is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Uffe Ravnskov has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 17 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Physiology. Recurrent topics in Uffe Ravnskov's work include Lipoproteins and Cardiovascular Health (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Diet and metabolism studies (9 papers). Uffe Ravnskov is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Diet and metabolism studies (9 papers). Uffe Ravnskov collaborates with scholars based in Sweden, United States and United Kingdom. Uffe Ravnskov's co-authors include Kevin K. McCully, Paul Rösch, David M. Diamond, Bengt G. Johansson, Malcolm Kendrick, Harumi Okuyama, B. Hultberg, Sherif Sultan, Tomohito Hamazaki and Staffan Skerfving and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Uffe Ravnskov

68 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uffe Ravnskov Sweden 23 532 375 295 256 238 75 1.9k
Erdembileg Anuurad United States 25 617 1.2× 654 1.7× 166 0.6× 328 1.3× 320 1.3× 55 2.3k
Garry X. Shen Canada 30 396 0.7× 394 1.1× 159 0.5× 329 1.3× 534 2.2× 99 2.3k
Avishay Elis Israel 21 458 0.9× 266 0.7× 133 0.5× 119 0.5× 274 1.2× 101 1.9k
Aleksandra Zeljković Serbia 23 583 1.1× 594 1.6× 247 0.8× 271 1.1× 312 1.3× 91 1.8k
A. W. Wahlefeld United States 10 364 0.7× 548 1.5× 93 0.3× 287 1.1× 329 1.4× 10 2.0k
Victorine Imrhan United States 14 318 0.6× 243 0.6× 148 0.5× 154 0.6× 432 1.8× 31 1.5k
Byambaa Enkhmaa United States 22 627 1.2× 592 1.6× 165 0.6× 325 1.3× 223 0.9× 54 1.9k
Thomas Sudhop Germany 30 1.7k 3.2× 426 1.1× 349 1.2× 362 1.4× 559 2.3× 61 3.3k
Filomena Morisco Italy 33 264 0.5× 616 1.6× 181 0.6× 275 1.1× 558 2.3× 166 3.8k
Montserrat Cofán Spain 29 802 1.5× 471 1.3× 219 0.7× 263 1.0× 448 1.9× 100 2.3k

Countries citing papers authored by Uffe Ravnskov

Since Specialization
Citations

This map shows the geographic impact of Uffe Ravnskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uffe Ravnskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uffe Ravnskov more than expected).

Fields of papers citing papers by Uffe Ravnskov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uffe Ravnskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uffe Ravnskov. The network helps show where Uffe Ravnskov may publish in the future.

Co-authorship network of co-authors of Uffe Ravnskov

This figure shows the co-authorship network connecting the top 25 collaborators of Uffe Ravnskov. A scholar is included among the top collaborators of Uffe Ravnskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uffe Ravnskov. Uffe Ravnskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravnskov, Uffe & Kevin K. McCully. (2024). The importance of LDL-cholesterol and infection in the etiology of cardiovascular disease: a meta-analysis of COVID-19 survivors and non-survivors. Medical Research Archives. 12(5). 1 indexed citations
2.
Ravnskov, Uffe, Abdullah Alabdulgader, & Kevin K. McCully. (2023). Infections May Cause Arterial Inflammation, Atherosclerosis, Myocarditis and Cardiovascular Disease. Medical Research Archives. 11(5). 2 indexed citations
3.
Ravnskov, Uffe, Michel de Lorgeril, Malcolm Kendrick, & David M. Diamond. (2018). Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia. Medical Hypotheses. 121. 60–63. 12 indexed citations
4.
Ravnskov, Uffe, David M. Diamond, Tomohito Hamazaki, et al.. (2016). Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 6(6). e010401–e010401. 207 indexed citations
5.
Diamond, David M. & Uffe Ravnskov. (2015). How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Review of Clinical Pharmacology. 8(2). 201–210. 39 indexed citations
6.
Ravnskov, Uffe, James J. DiNicolantonio, Zoë Harcombe, et al.. (2014). The Questionable Benefits of Exchanging Saturated Fat With Polyunsaturated Fat. Mayo Clinic Proceedings. 89(4). 451–453. 22 indexed citations
7.
Ravnskov, Uffe & Kevin K. McCully. (2012). Infections May be Causal in the Pathogenesis of Atherosclerosis. The American Journal of the Medical Sciences. 344(5). 391–394. 38 indexed citations
8.
Ravnskov, Uffe. (2010). Mythos Cholesterin. 1 indexed citations
9.
Ravnskov, Uffe. (2008). The fallacies of the lipid hypothesis. Scandinavian Cardiovascular Journal. 42(4). 236–239. 11 indexed citations
10.
Ravnskov, Uffe. (2006). Saturated fat does not affect blood cholesterol. American Journal of Clinical Nutrition. 84(6). 1550–1551.
11.
Ravnskov, Uffe, Paul Rösch, Morley C. Sutter, & Mark C. Houston. (2006). Should we lower cholesterol as much as possible?. BMJ. 332(7553). 1330–1332. 31 indexed citations
12.
Ravnskov, Uffe. (2003). High cholesterol may protect against infections and atherosclerosis. QJM. 96(12). 927–934. 83 indexed citations
13.
Ravnskov, Uffe. (2002). Is atherosclerosis caused by high cholesterol?. QJM. 95(6). 397–403. 47 indexed citations
14.
Ravnskov, Uffe. (2002). A hypothesis out-of-date. Journal of Clinical Epidemiology. 55(11). 1057–1063. 32 indexed citations
15.
Ravnskov, Uffe. (2001). [Millions of healthy people can be considered ill because of the American cholesterol policy].. PubMed. 98(42). 4574–7. 1 indexed citations
16.
17.
Ravnskov, Uffe. (1998). The Subepithelial Formation of Immune Complexes in Membranous Glomerulonephritis may be Harmless and Secondary to Toxic or Allergic Factors. Scandinavian Journal of Immunology. 48(5). 469–474. 6 indexed citations
18.
Ravnskov, Uffe. (1996). American College of Physicians Guidelines on Cholesterol Screening. Annals of Internal Medicine. 125(12). 1010–1011. 3 indexed citations
19.
Ravnskov, Uffe. (1990). Lowering cholesterol concentrations and mortality. BMJ. 301(6755). 814.3–814. 3 indexed citations
20.
Ravnskov, Uffe. (1975). Low molecular weight proteinuria in association with paroxysmal myoglobinuria.. PubMed. 3(2). 65–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erdembileg Anuurad Breakdown of academic impact, for papers by Garry X. Shen Breakdown of academic impact, for papers by Avishay Elis Breakdown of academic impact, for papers by Aleksandra Zeljković Breakdown of academic impact, for papers by A. W. Wahlefeld Breakdown of academic impact, for papers by Victorine Imrhan Breakdown of academic impact, for papers by Byambaa Enkhmaa Breakdown of academic impact, for papers by Thomas Sudhop Breakdown of academic impact, for papers by Filomena Morisco Breakdown of academic impact, for papers by Montserrat Cofán
Rankless by CCL
2026